About
Neo7Bioscience develops personalized peptide designs for patients facing active diseases such as cancer, autoimmune conditions, neurodegenerative disorders, viral infections, and chronic illnesses. The company uses AI and multiomics to create precision-based immuno-molecular augmentation, tailoring treatments to individual needs. This approach supports disease management, prevention, and health optimization through measured, strategic interventions.
Founded by Dr. John Catanzaro, Neo7Bioscience focuses on precise molecular designs informed by genomics, proteomics, and peptide engineering. They integrate advanced technologies to deliver integrated solutions for complex health challenges. Patients benefit from customized therapies aimed at sustainable outcomes.
Longevity Contribution
- Precision-based immuno-molecular augmentation using AI and multiomics
- Personalized peptide designs for specific diseases like cancer and autoimmune conditions
- Focus on both disease combat and health optimization
- Application of systems biology for deep space and orbit technologies adapted to medicine